Commercialization: Page 40
-
PharmaVoice Team/PharmaVoice
Caring for Those with Brain Disorders
Many of us will be caregivers at some point in our lives. Age, debilitating disease, and chronic health conditions mean many of us will take on the role of caring for relatives. An estimated 43.5 million adults in the United States have provided unpaid care to an adult or a child in the prior 12 ...
By Denise Myshko • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Despite Turbulence, Russia's Pharma Market Holds Promise
The world’s largest nation, Russia remains an attractive market for most industries. Nevertheless, the country has struggled through a rough economic period, rocked by a drop in the value of the currency and turbulence in the oil market. Geopolitical pressures have raised challenges, including sa...
By Kim Ribbink • March 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Market Research
MarketResearch.com asked a variety of executives and thought leaders to share their predictions on the trends market researchers should expect in 2016 (see box: 15 Predicted Market Research Trends for 2016). These respondents cited a range of influential factors, including the role of mobile devi...
By Taren Grom • March 1, 2016 -
PharmaVoice Team/PharmaVoice
For Optimized Brand Strategies, Look to Market Research
Mark Twain is one of our favorite authors — and not just because of classics like The Adventures of Tom Sawyer and its sequel The Adventures of Huckleberry Finn, but also for an array of funny quotes, such as “Get your facts first, and then you can distort them as much as you please." That partic...
By Lori Gittleman • March 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Astellas Partners with Aspiritech to Advance Opportunities for Adults with Autism By harnessing the strengths of adults with high-functioning autism — attention to detail, precision, an affinity for repetitive tasks, and outstanding technology skills — Aspiritech is providing so...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Researching Gene Therapies for Rare Diseases Karen Aiach, Founder and CEO of Lysogene, talks about the company’s mission to become experts in gene vector delivery to the brain. Diseases of the central nervous system are a challenge to treat because the blood brain barrier prevents large molecules...
By Karen Aiach • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Novartis and Qualcomm’s Inhaler Device Helps Manage COPD Trendwatch: Apps and devices create better patient connectivity. Novartis and Qualcomm have collaborated to create the Breezhaler inhaler device to treat COPD. Under this partnership, Qualcomm Life will provide the technology solution for t...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
Baxalta Opens Global Innovation Center Trending now: Baxalta joins growing list of Cambridge, Mass.-based innovators Baxalta, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, has opened its Global Inno...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Veeva Systems and UL EduNeering Partner to Deliver Integrated Learning Solution Trending Now: The partnership marries industry cloud solutions to improve quality and compliance across the value chain. UL EduNeering is delivering a connector integrating Veeva Vault QualityDocs, a cloud-based life...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Pennsylvania BIO 2016 Annual Dinner and Awards Celebration is the premier event of the season for the life-sciences industry in Pennsylvania. On March 10th, more than 1,000 attendees will convene for this can’t-miss event Thursday, March 10, 2016, at the PA Convention Cente...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Global Launches
Most of today’s new therapy launches are global, but the strategy behind those launches has changed significantly, due to the advent of more specialty drugs targeting smaller populations, and the impact of the shift in decision making from physician to payer. The industry can no longer rely on ph...
By Robin Robinson • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Advertising to Segments of the Customer Base
For many marketers today, audience segmentation is becoming a key strategic activity when conducting audience analysis. At the most basic level, audience segmentation is the process of dividing a large group of people into homogeneous subgroups — or segments — based upon those who have similar ne...
By Taren Grom • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Coming Antibiotic Crisis
For the last 70 years, antibiotics have greatly reduced illness and death from infectious diseases. But these drugs have been used so widely and for so long that the infectious organisms the antibiotics are designed to kill have adapted to them, making the drugs less effective. In the past 25 yea...
By Denise Myshko • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Patients and Patient Organizations Power Rare Disease Therapies
For most of the pharmaceutical industry, the focus on patient centricity is a relatively new phenomenon, and the industry continues to shift its focus to include patients as stakeholders when planning its marketing strategies, clinical trials, and R&D strategies. However, for the rare disease...
By Robin Robinson • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Mental Illness: An Underserved Area
Advances in brain science and the understanding of mental health disorders have led to the approval of new medicines, but mental health disorders still take a huge toll on Americans. The National Institute of Mental Health (NIMH) estimates that one in four American adults — 61.5 million people — ...
By Denise Myshko • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Alzheimer's Research Update
Alzheimer’s is at the forefront of brain research; 90% of what we know about Alzheimer’s has been discovered in the last 15 years. But while research has discovered much about this devastating disease, there is still much we don’t know. Alzheimer’s is one of the most complex diseases researchers ...
By Denise Myshko • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Quiet Achiever: Japan Puts Focus On Innovation
A s one of the world’s biggest economies and a well-established pharmaceutical powerhouse, Japan has for many years been a difficult market for foreign companies to enter independently. Increasingly, however, the Japanese market is opening to international companies. “In the past companies were e...
By Kim Ribbink • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Year Ahead Last month we identified 10 mega-trends that we, as well as others, think will impact the industry going forward. One of these trends is the increasing focus on the brain and the research efforts ongoing to understand the mysteries of this three-pound organ. And while scientists h...
By Taren Grom • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Helping Kids with Asthma Medikidz and Meda Pharmaceuticals have launched Explain Asthma, a comic book series launched in conjunction with the American College of Asthma, Allergy, and Immunology (ACAAI). The series is designed to help families gain an accurate understanding of as...
By PharmaVoice Team • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Quintiles Contributes Open Source Code to ResearchKit Trending Now: Enhancements enable patient engagement tools for ResearchKit-based apps. Quintiles has contributed enhancements to the ResearchKit framework that provide developers with extensions that support additional capabilities, which, in...
By PharmaVoice Team • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
New Agency Brand Architecture Trending now: Publicis Health Media launches new model across its three U.S. hubs. Publicis Health Media (PHM) has launched a new branding architecture, affecting its three key office locations in Philadelphia, New York, and Chicago. The strategic branding restruct...
By PharmaVoice Team • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Adverse Drug Event Reporting in U.S. Plagued by Incompleteness and Inaccuracy Trending now: A high proportion of healthcare professionals have no ADE reporting experience. Voluntary adverse drug event (ADE) reporting in the United States is incomplete, inaccurate, and inefficient, which could den...
By PharmaVoice Team • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
PerkinElmer Launches Signals for Translational Trending Now: New cloud-based informatics platform supports complete precision medicine workflow. PerkinElmer has launched PerkinElmer Signals for Translational, a cloud-based data management, aggregation, and analysis platform for pharmaceutical...
By PharmaVoice Team • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The 7th Annual SCOPE Summit, Feb. 23-25, 2016, Miami, offers three stimulating days of in-depth discussions in 12 different conferences, four pre-conference workshops, and two symposia focused on issues related to each aspect of clinical trial planning and management: data inte...
By PharmaVoice Team • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Brain: The Decade Ahead
The three-pound organ — made up of more than 100 billion nerves — that serves as the center of the nervous system is one of the most complex parts of the human body. Only recently have researchers and scientists begun to understand the brain and what can go wrong. This special forum kicks off a y...
By Denise Myshko and Robin Robinson • Jan. 1, 2016
Previous
